The Journal of Emergency Medicine
Volume 30, Issue 4 , Pages 407-410, May 2006

Systemic toxicity after an ocular exposure to xylazine hydrochloride

  • Larissa I. Velez, MD, FACEP

      Affiliations

    • Department of Surgery, Division of Emergency Medicine, Section of Toxicology, University of Texas Southwestern Medical Center, Dallas, Texas
    • Corresponding Author InformationReprint Address: Larissa I. Velez, md, Department of Emergency Medicine, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX 75390-8579
  • ,
  • Greene Shepherd, PHARMD, DABAT

      Affiliations

    • Department of Emergency Medicine, University of Georgia, College of Pharmacy and Medical College of Georgia, Augusta, Georgia
  • ,
  • Lisa D. Mills, MD

      Affiliations

    • Department of Internal Medicine, Section of Emergency Medicine, Louisiana State University Health Sciences Center at New Orleans, New Orleans, Louisiana
  • ,
  • Wilfredo Rivera, MD

      Affiliations

    • Department of Surgery, Division of Emergency Medicine, Section of Toxicology, University of Texas Southwestern Medical Center, Dallas, Texas

Received 18 June 2004; received in revised form 30 March 2005; accepted 25 July 2005.

Abstract 

There are limited reports of human overdose with the animal tranquilizer, xylazine hydrochloride. The reported effects include hypotension, bradycardia, and respiratory depression. Ocular exposures to xylazine have not been previously reported. A 38-year-old man arrived in the Emergency Department, reporting the accidental irrigation of both eyes with approximately 8 mL of xylazine (100 mg/mL) 30 min before arrival. The patient was asymptomatic. The eyes were copiously irrigated with isotonic crystalloid. Two hours after the exposure, the patient developed sinus bradycardia (40–50 beats/min), hypotension (90/60 mm Hg), and a decreased level of consciousness. The patient was admitted for observation, during which the bradycardia and hypotension were noted to persist. He remained otherwise asymptomatic. The symptoms resolved without intervention, other than i.v. fluids, approximately 25 h after the exposure. The patient was discharged home. This case demonstrates that ocular exposure to xylazine can cause systemic central nervous system and cardiovascular effects.

Keywords:  toxicology , xylazine , eye , toxicity , hypotension

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0736-4679(06)00112-0

doi:10.1016/j.jemermed.2006.02.042

The Journal of Emergency Medicine
Volume 30, Issue 4 , Pages 407-410, May 2006